Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Javier Vázquez-Bourgon has a total of 802 co-authors. Here are the top co-authors by number of shared publications:

  • Benedicto Crespo-Facorro

    Mental Health Service, Virgen del Rocío University Hospital; Seville, Spain. Instituto de Biomedicina de Sevilla (IBiS) HUVR/CSIC/University of Seville / CIBERSAM, ISCIII, Seville, Spain

    33 shared publications
  • Rosa Ayesa-Arriola

    Department of Psychiatry, Marqués de Valdecilla University Hospital-IDIVAL, Santander, Spain; Centro Investigación Biomédica en Red Salud Mental (CIBERSAM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain

    19 shared publications
  • Benedicto Crespo-Facorro

    Translational Psychiatry Group, Institute of Biomedicine of Seville (IBiS), Seville, Spain

    17 shared publications
  • Víctor Ortiz-García de la Foz

    Instituto de Investigación Marqués de Valdecilla

    16 shared publications
  • Rosa Ayesa-Arriola

    Department of Psychiatry. Marqués de Valdecilla University Hospital, IDIVAL, CIBERSAM, ISCIII, School of Medicine, University of Cantabria, Santander, Spain

    11 shared publications
  • Marcos Gómez-Revuelta

    University Hospital Marqués de Valdecilla, IDIVAL Research Foundation, Department of Psychiatry, School of Medicine, University of Cantabria, Avda. Valdecilla n 25, 39008, SANTANDER, Cantabria, Santander, Spain

    10 shared publications

Latest Publications

  • Open Access

    Early deviations from normative brain morphology and cortical microstructure in schizophrenia spectrum disorders

    by Claudio Alemán-Morillo, Natalia García-San-Martín, Richard Ai Bethlehem, Patricia Segura, Chloé Gomez, Alessia Pasquini, Pablo Salguero-Quirós, Lena Dorfschmidt, Manuel Muñoz-Caracuel, Rosa Ayesa-Arriola, et al.

    In schizophrenia spectrum disorders (SSD), structural alterations of the gray matter (GM) and white matter (WM) have been widely described. However, the complex interplay between early disease-related changes and ongoing brain maturation challenges our ability to identify early biomarkers. In this study, we investigated structural abnormalities and their association with symptoms in a drug-naïve or minimally medicated sample comprising 113 patients with SSD and 112 neurotypical controls. Specifically, we derived centile scores using normative modelling from cortical thickness (CT), and subcortical volumes derived from structural MRI images, and diffusion tensor imaging-derived (DTI) WM tract fractional anisotropy (FA). In addition, we derived raw cortical mean diffusivity (cMD) metrics from DTI. Compared to controls, SSD participants showed reduced CT centiles, ventricular enlargement, and subcortical centile reductions in the hippocampus, thalamus, amygdala, and nucleus accumbens. SSD was also associated with widespread increases in cMD. We also explored associations among these structural markers, identifying significant relationships between CT centiles and raw cMD, as well as between subcortical centiles and FA tract-based centiles. No interaction with SSD diagnosis was found. Furthermore, positive symptoms correlated negatively with CT and FA tract-based centiles, and showed widespread positive associations with raw cMD, whereas negative symptoms showed no associations. These findings underscore multimodal brain abnormalities that originate early in the course of SSD and their distinct associations with symptoms. Our results support the potential of both normative modelling and diffusion imaging markers to identify individualized early brain changes in SSD Among these, cMD emerges as a potential marker of SSD-related microstructural alterations.

  • Open Access

    Reduced brain structural similarity is associated with maturation, neurobiological features, and clinical status in schizophrenia

    by Natalia García-San-Martín, Richard Ai Bethlehem, Patricia Segura, Agoston Mihalik, Jakob Seidlitz, Isaac Sebenius, Claudio Alemán-Morillo, Lena Dorfschmidt, Golia Shafiei, Sarah E. Morgan, et al.

    Schizophrenia spectrum disorders (SSD) are characterized by atypical brain maturation, including alterations in structural similarity between regions. Using structural MRI data from 195 healthy controls (HC) and 352 individuals with SSD, we construct individual Morphometric INverse Divergence (MIND) networks. Compared to HC, individuals with SSD mainly exhibit reduced structural similarity in the temporal, cingulate, and insular lobes, being more pronounced in individuals exhibiting a ‘poor’ clinical status (more impaired cognitive functioning and more severe symptomatology). These alterations are associated with cortical hierarchy and maturational events, locating MIND reductions in higher-order association areas that mature later. Finally, we map 46 neurobiological features onto MIND networks, revealing a high presence of neurotransmitters and astrocytes, along with decreased metabolism and microstructure, in regions with reduced similarity in SSD. These findings provide evidence on the complex interplay between structural similarity, maturational events, and the underlying neurobiology in determining clinical status of individuals with SSD.


  • Genomic analysis of intracranial and subcortical brain volumes yields polygenic scores accounting for variation across ancestries

    by Luis M García-Marín, Adrian I Campos, Santiago Diaz-Torres, Jill A Rabinowitz, Zuriel Ceja, Brittany L Mitchell, Katrina L Grasby, Jackson G Thorp, Ingrid Agartz, Saud Alhusaini, et al.

    Subcortical brain structures are involved in developmental, psychiatric and neurological disorders. Here we performed genome-wide association studies meta-analyses of intracranial and nine subcortical brain volumes (brainstem, caudate nucleus, putamen, hippocampus, globus pallidus, thalamus, nucleus accumbens, amygdala and the ventral diencephalon) in 74,898 participants of European ancestry. We identified 254 independent loci associated with these brain volumes, explaining up to 35% of phenotypic variance. We observed gene expression in specific neural cell types across differentiation time points, including genes involved in intracellular signaling and brain aging-related processes. Polygenic scores for brain volumes showed predictive ability when applied to individuals of diverse ancestries. We observed causal genetic effects of brain volumes with Parkinson’s disease and attention-deficit/hyperactivity disorder. Findings implicate specific gene expression patterns in brain development and genetic variants in comorbid neuropsychiatric disorders, which could point to a brain substrate and region of action for risk genes implicated in brain diseases.


  • Open Access

    Molecular and micro-architectural mapping of gray matter alterations in psychosis

    by Natalia García-San-Martín, Richard A. I. Bethlehem, Agoston Mihalik, Jakob Seidlitz, Isaac Sebenius, Claudio Alemán-Morillo, Lena Dorfschmidt, Golia Shafiei, Víctor Ortiz-García de la Foz, Kate Merritt, et al.

    The psychosis spectrum encompasses a heterogeneous range of clinical conditions associated with abnormal brain development. Detecting patterns of atypical neuroanatomical maturation across psychiatric disorders requires an interpretable metric standardized by age-, sex- and site-effect. The molecular and micro-architectural attributes that account for these deviations in brain structure from typical neurodevelopment are still unknown. Here, we aggregate structural magnetic resonance imaging data from 38,696 healthy controls (HC) and 1256 psychosis-related conditions, including first-degree relatives of schizophrenia (SCZ) and schizoaffective disorder (SAD) patients (n = 160), individuals who had psychotic experiences (n = 157), patients who experienced a first episode of psychosis (FEP, n = 352), and individuals with chronic SCZ or SAD (n = 587). Using a normative modeling approach, we generated centile scores for cortical gray matter (GM) phenotypes, identifying deviations in regional volumes below the expected trajectory for all conditions, with a greater impact on the clinically diagnosed ones, FEP and chronic. Additionally, we mapped 46 neurobiological features from healthy individuals (including neurotransmitters, cell types, layer thickness, microstructure, cortical expansion, and metabolism) to these abnormal centiles using a multivariate approach. Results revealed that neurobiological features were highly co-localized with centile deviations, where metabolism (e.g., cerebral metabolic rate of oxygen (CMRGlu) and cerebral blood flow (CBF)) and neurotransmitter concentrations (e.g., serotonin (5-HT) and acetylcholine (α4β2) receptors) showed the most consistent spatial overlap with abnormal GM trajectories. Taken together these findings shed light on the vulnerability factors that may underlie atypical brain maturation during different stages of psychosis.


  • Increased risk of early lung function alterations in people with psychosis: A cross-sectional case–control study

    by Ana Viejo Casas, Carlos Amado Diago, Juan Agüero Calvo, Marcos Gómez-Revuelta, Paula Suarez Pinilla, Claudia Ovejas Catalán, Paloma Fuentes Pérez, Mario Ruiz Núñez, Roberto Garrastazu López, María Juncal Ruiz, et al.

  • Open Access

    Individuals with psychosis present a reduced lung diffusion capacity and early spirometry alterations: Results from a cross-sectional study

    by Ana Viejo Casas, Carlos Amado Diago, Juan Agüero Calvo, Marcos Gómez-Revuelta, Mario Ruiz Núñez, María Juncal-Ruiz, Rocío Pérez-Iglesias, Paloma Fuentes-Pérez, Benedicto Crespo-Facorro, Javier Vázquez-Bourgon


  • Open Access

    Estudio observacional comparativo de un año de duración del impacto de la pandemia por COVID-19 en el desarrollo de síntomas de ansiedad y de depresión entre 100 niños y adolescentes en tratamiento en una Unidad de Salud Mental y 93 voluntarios sanos

    by María Juncal-Ruiz, María Ruiz-Torres, Nuria Diego-Falagán, Carmen Batz-Colvée, Teresa Becerril-Ruiz, Susana Samaniego-Peña, Elsa García-Rumayor, Iban Onandia-Hinchado, Ana María Gutiérrez-Pérez, Rosa Ayesa-Arriola, et al.

    La pandemia por COVID-19 ha generado una preocupación creciente por su posible impacto en la salud mental de niños y adolescentes. En este estudio hemos comparado la presencia de síntomas de ansiedad y de depresión en una muestra de 100 niños y adolescentes en tratamiento en una Unidad de Salud Mental Infanto-Juvenil y 93 voluntarios sanos durante el primer año desde el inicio de la pandemia COVID-19. Asimismo, hemos analizado si la edad o el sexo podrían actuar como factores de riesgo para el desarrollo de estos síntomas en ambos grupos. Los resultados obtenidos sugieren que las mujeres adolescentes con antecedentes de problemas relacionados con la salud mental son las personas más vulnerables para desarrollar síntomas de ansiedad y depresión durante una crisis sanitaria, como la pandemia por COVID-19, y, por lo tanto, tenerlas en cuenta en los programas de detección, prevención e intervención precoz que se lleven a cabo.


  • Open Access

    Correction: Obesity and brain structure in schizophrenia – ENIGMA study in 3021 individuals

    by Sean R. McWhinney, Katharina Brosch, Vince D. Calhoun, Benedicto Crespo-Facorro, Nicolas A. Crossley, Udo Dannlowski, Erin Dickie, Lorielle M. F. Dietze, Gary Donohoe, Stefan Du Plessis, et al.


  • Top Cited Papers
    Open Access

    Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium

    by Dick Schijven, Merel C. Postema, Masaki Fukunaga, Junya Matsumoto, Kenichiro Miura, Sonja M. C. de Zwarte, Neeltje E. M. van Haren, Wiepke Cahn, Hilleke E. Hulshoff Pol, René S. Kahn, et al.

    Left–right asymmetry is an important organizing feature of the healthy brain that may be altered in schizophrenia, but most studies have used relatively small samples and heterogeneous approaches, resulting in equivocal findings. We carried out the largest case–control study of structural brain asymmetries in schizophrenia, with MRI data from 5,080 affected individuals and 6,015 controls across 46 datasets, using a single image analysis protocol. Asymmetry indexes were calculated for global and regional cortical thickness, surface area, and subcortical volume measures. Differences of asymmetry were calculated between affected individuals and controls per dataset, and effect sizes were meta-analyzed across datasets. Small average case–control differences were observed for thickness asymmetries of the rostral anterior cingulate and the middle temporal gyrus, both driven by thinner left-hemispheric cortices in schizophrenia. Analyses of these asymmetries with respect to the use of antipsychotic medication and other clinical variables did not show any significant associations. Assessment of age- and sex-specific effects revealed a stronger average leftward asymmetry of pallidum volume between older cases and controls. Case–control differences in a multivariate context were assessed in a subset of the data (N = 2,029), which revealed that 7% of the variance across all structural asymmetries was explained by case–control status. Subtle case–control differences of brain macrostructural asymmetry may reflect differences at the molecular, cytoarchitectonic, or circuit levels that have functional relevance for the disorder. Reduced left middle temporal cortical thickness is consistent with altered left-hemisphere language network organization in schizophrenia.


  • Open Access

    Polygenic risk scores enhance prediction of body mass index increase in individuals with a first episode of psychosis

    by Gerard Muntané, Javier Vázquez-Bourgon, Ester Sada, Lourdes Martorell, Sergi Papiol, Elena Bosch, Arcadi Navarro, Benedicto Crespo-Facorro, Elisabet Vilella

    Background: Individuals with a first episode of psychosis (FEP) show rapid weight gain during the first months of treatment, which is associated with a reduction in general physical health. Although genetics is assumed to be a significant contributor to weight gain, its exact role is unknown. Methods: We assembled a population-based FEP cohort of 381 individuals that was split into a Training (n = 224) set and a Validation (n = 157) set to calculate the polygenic risk score (PRS) in a two-step process. In parallel, we obtained reference genome-wide association studies for body mass index (BMI) and schizophrenia (SCZ) to examine the pleiotropic landscape between the two traits. BMI PRSs were added to linear models that included sociodemographic and clinical variables to predict BMI increase (∆BMI) in the Validation set. Results: The results confirmed considerable shared genetic susceptibility for the two traits involving 449 near-independent genomic loci. The inclusion of BMI PRSs significantly improved the prediction of ∆BMI at 12 months after the onset of antipsychotic treatment by 49.4% compared to a clinical model. In addition, we demonstrated that the PRS containing pleiotropic information between BMI and SCZ predicted ∆BMI better at 3 (12.2%) and 12 months (53.2%). Conclusions: We prove for the first time that genetic factors play a key role in determining ∆BMI during the FEP. This finding has important clinical implications for the early identification of individuals most vulnerable to weight gain and highlights the importance of examining genetic pleiotropy in the context of medically important comorbidities for predicting future outcomes.